Study of PFLotus for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new device called PFLotus for people with persistent atrial fibrillation (AF), a type of irregular heartbeat. The goal is to see if it can help restore a normal heart rhythm in people who haven't gotten better with medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with persistent atrial fibrillation (AF) that lasts longer than 7 days and causes symptoms.
- You have tried at least one heart rhythm medicine and it didn't work well or caused side effects.
- You have not had a previous catheter ablation or heart surgery for AF.
- You do not have other serious health problems like heart failure, blood clotting issues, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter (PFLotus) with a special mapping system to help treat people with persistent atrial fibrillation (a long-lasting irregular heartbeat). The goal is to see if it can safely and effectively restore a normal heart rhythm.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This study tests a new heart procedure using pulsed field ablation (a type of energy to fix irregular heartbeats) for people who have had atrial fibrillation for less than a year. It may help restore a normal heart rhythm and reduce symptoms.
This trial tests a more precise way to burn (ablate) the back wall of the left upper heart chamber during the first ablation for persistent atrial fibrillation (AF). It aims to improve heart rhythm control and reduce the chance of AF coming back.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.